|
|
Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of Tauopathies |
| 1 F30 AG067673-01A1 |
|
NIA |
2021 |
|
|
Defining the cell-autonomous role of caveolin-1 in adult hippocampal neurogenesis in Alzheimer's Disease |
| 1 F30 AG071144-01A1 |
|
NIA |
2021 |
|
|
Actigraphic Assessment of Sleep and Circadian Rest/Activity Rhythms in Persons with Alzheimer's Disease and their Caregivers |
| 1 F30 AG071169-01A1 |
|
NIA |
2021 |
|
|
Statistical developments for biomarker and diagnostic test evaluation with applications to Alzheimers disease |
| 1 F30 AG071349-01 |
|
NIA |
2021 |
|
|
Enhancing Exercise Intensity, Motivation and Enjoyment for Persons with PD: Comparing Visual Feedback and Competition in A Virtual Cycling Environment (VCYCLE) |
| 1 F30 AG072807-01 |
|
NIA |
2021 |
|
|
Alzheimer's Disease Genetic Risk and Microglial Innate Immune Memory |
| 1 F30 AG074618-01 |
|
NIA |
2021 |
|
|
Investigating the Neuronal Signals Initiating Synapse Loss in Aging and Alzheimer's Disease |
| 1 F30 AG074629-01 |
|
NIA |
2021 |
|
|
Effects of apolipoprotein E isoform and amifostine on memory-related DNA double strand breaks and immediate-early gene expression |
| 1 F31 AG067629-01A1 |
|
NIA |
2021 |
|
|
Targeting multiple Wnt inhibitors for synergistic anabolic action in the skeleton |
| 1 F31 AG069489-01A1 |
|
NIA |
2021 |
|
|
Alternative Splicing of ApoER2 in Alzheimers Disease |
| 1 F31 AG069498-01A1 |
|
NIA |
2021 |
